N-substituted indole derivatives as PGE2 receptor modulators
US12011444B2 · kind B2 · utility
1Cited by
6References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 2021 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Mar 9, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to derivatives of formula (I) wherein (R1)n, R2, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.